As decreased expression of the miR-34a targets, MET and Axl is associated with the induction of autophagy [29, 30], understanding the form of autophagy induced by miR-34a in prostate cancer is important for therapeutic opportunities for miR-34a replacement in bone metastatic prostate cancer. This evidence concerns the gene MET and Familial prostate cancer.